bioAffinity Technologies receives US patent allowance for lung cancer test
Go back to bioAffinity Technologies receives US patent allowance for lung cancer test| (NASDAQ: BIAF) | Delayed: 0.86 +0.02 (2.38%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.84 | 52 Week High | $ | |||
| Open | $0.82 | 52 Week Low | $ | |||
| Day High | $0.87 | P/E | N/A | |||
| Day Low | $0.82 | EPS | $ | |||
| Volume | 287,097 | |||||
| (NASDAQ: BIAFW) | Delayed: 0.14 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.14 | 52 Week High | $ | |||
| Open | $0.14 | 52 Week Low | $ | |||
| Day High | $0.14 | P/E | N/A | |||
| Day Low | $0.14 | EPS | $ | |||
| Volume | 2,429,247 | |||||

